21-12-2012

Saltigo GmbH will be raising its prices for the product group 1,2,4-triazole by 1.65/kg effective January 1, 2013. The reasons for the measure are increases in raw material, energy and logistic costs. In light of the increase in operational costs associated with the production and to secure ...

more

LANXESS’ subsidiary again awarded by Syngenta for outstanding relationship

22-06-2012

Syngenta has presented Saltigo GmbH with an award for its commitment and contribution to the partnership between both companies. Saltigo received the Global Sourcing Award of Recognition 2012 for Partnership at the Syngenta Supplier Conference, held during the ChemSpec Europe chemistry trade ...

more

Joerg Schneider succeeds Uwe Brunk

24-01-2012

Effective February 1, 2012, Joerg Schneider, Managing Director of LANXESS Elastômeros do Brasil S.A., will assume management of the Agro & Fine Chemicals business line of Saltigo GmbH. The 49-year-old will succeed Dr. Uwe Brunk, who is leaving the company at his own request. Schneider began ...

more

Nobel Prize-winning chemistry in industrial use

28-10-2010

Palladium-catalyzed cross-coupling reactions have become an important cornerstone of modern organic synthesis chemistry. They have made a wide variety of active pharmaceutical ingredients, natural substances and other complex organic molecules economically accessible. The award of this year's ...

more

04-10-2010

Saltigo GmbH, the specialist in custom synthesis based in Langenfeld, Germany, and Reuter Chemische Apparatebau KG (RCA) of Freiburg, Germany, concluded a cooperation agreement on October 1. The companies will jointly develop processes for the synthesis of active pharmaceutical ingredients ...

more

26-08-2010

Saltigo GmbH will be raising its prices for the product group 1,2,4 Triazol (CAS 00288-88-0) by 10 % effective September 1, 2010. The reasons for the measure are substantial increases in raw materials and energy costs.

more

28-06-2010

Saltigo GmbH has passed an audit by the U.S. Food and Drug Administration (FDA) with a “No Findings” rating. Saltigo’s Managing Director Wolfgang Schmitz is delighted that the official auditors did not have any objections: “The FDA audit is an internationally accredited seal of quality and ...

more

Syngenta invests around EUR 50 million in Saltigo facilities

06-05-2010

Saltigo, a wholly owned subsidiary of LANXESS, is significantly expanding production at its Leverkusen site. This is being made possible by a cooperation agreement that is so far unique for the Group. Syngenta is investing some EUR 50 million in expanding several Saltigo facilities in ...

more

LANXESS subsidiary wins “Agrow Award 2009”

17-11-2009

Saltigo GmbH, a wholly owned subsidiary of LANXESS, has been rated as “Best Supplier” by the “Agrow” trade journal for the second time in succession and won against a strong competition from India, China and Europe. A panel of judges comprising eleven internationally recognized experts from ...

more

02-07-2009

Saltigo GmbH targets Japanese custom manufacturing market, presenting its portfolio of services at Interphex/Pharma-i Japan Exhibition in Tokyo. Saltigo’s CEO Wolfgang Schmitz emphasizes: “This is Asia’s largest pharmaceutical industry event and has an excellent reputation for attracting key ...

more